Involvement of activator protein-1 in transcriptional regulation of the human μ-opioid receptor gene

被引:49
作者
Börner, C [1 ]
Höllt, V [1 ]
Kraus, J [1 ]
机构
[1] Univ Magdeburg, Dept Pharmacol, D-39106 Magdeburg, Germany
关键词
D O I
10.1124/mol.61.4.800
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
mu-Opioid receptors mediate such opioid effects as analgesia, euphoria, and immunomodulation. Gene expression of mu-opioid receptors can be modulated by various substances, including cytokines, hormones, and drugs. Some of these stimuli (e. g., IL-1beta and cocaine) have been shown to activate members of the AP-1 transcription factor family. In addition, transcription of the mu-opioid receptor gene is induced by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA), an activator of protein kinase C, which in turn is an activator of AP-1 transcription factors. This indicates that signaling pathways involving protein kinase C and activator protein 1 (AP-1) transcription factors are important for the specific expression pattern of the mu-opioid receptor gene. In this report, we show that TPA activates AP-1 as well as the transcription factor nuclear factor kappaB (NFkappaB) in the mu-opioid receptor expressing neuroblastoma cell line SH SY5Y. In transfection experiments performed in these cells, both factors trans-activate expression of reporter gene constructs containing the human mu-opioid receptor gene promoter. By excluding the effects of TPA on NFkappaB with the specific NFkappaB inhibitor sulfasalazine, AP-1 regulatory elements were localized. Two AP-1 elements, which differ in one nucleotide each from the classic AP-1 binding site, were delineated to positions -2388 and -1434 of the promoter. Independent of their orientation, these elements conferred TPA responsiveness on the heterologous thymidine kinase promoter. AP-1 binding to these elements was confirmed using electrophoretic mobility shift and immunoshift assays.
引用
收藏
页码:800 / 805
页数:6
相关论文
共 39 条
[1]   PHORBOL ESTER INDUCIBLE GENES CONTAIN A COMMON CIS ELEMENT RECOGNIZED BY A TPA-MODULATED TRANS-ACTING FACTOR [J].
ANGEL, P ;
IMAGAWA, M ;
CHIU, R ;
STEIN, B ;
IMBRA, RJ ;
RAHMSDORF, HJ ;
JONAT, C ;
HERRLICH, P ;
KARIN, M .
CELL, 1987, 49 (06) :729-739
[2]  
Azaryan AV, 1996, J NEUROCHEM, V66, P443
[3]   Presence of a reduced opioid response in interleukin-6 knock out mice [J].
Bianchi, M ;
Maggi, R ;
Pimpinelli, F ;
Rubino, T ;
Parolaro, D ;
Poli, V ;
Ciliberto, G ;
Panerai, AE ;
Sacerdote, P .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1999, 11 (05) :1501-1507
[4]  
BRADY LS, 1994, J NEUROSCI, V14, P4951
[5]   HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].
CHEN, C ;
OKAYAMA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752
[6]   PERIPHERAL MECHANISMS OF OPIOID ANTINOCICEPTION IN INFLAMMATION - INVOLVEMENT OF CYTOKINES [J].
CZLONKOWSKI, A ;
STEIN, C ;
HERZ, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 242 (03) :229-235
[7]   Acute injection of drugs with low addictive potential (Δ9-tetrahydrocannabinol, 3,4-methylenedioxymethamphetamine, lysergic acid diamide) causes a much higher c-fos expression in limbic brain areas than highly addicting drugs (cocaine and morphine) [J].
Erdtmann-Vourliotis, M ;
Mayer, P ;
Riechert, U ;
Höllt, V .
MOLECULAR BRAIN RESEARCH, 1999, 71 (02) :313-324
[8]   ADENOSINE A(2B) RECEPTOR SIGNALING IS ALTERED BY STIMULATION OF BRADYKININ OR INTERLEUKIN RECEPTORS IN ASTROGLIOMA CELLS [J].
FREDHOLM, BB ;
ALTIOK, N .
NEUROCHEMISTRY INTERNATIONAL, 1994, 25 (01) :99-102
[9]   Abolition of morphine-immunosuppression in mice lacking the μ-opioid receptor gene [J].
Gavériaux-Ruff, C ;
Matthes, HWD ;
Peluso, J ;
Kieffer, BL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6326-6330
[10]   Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins [J].
Herdegen, T ;
Leah, JD .
BRAIN RESEARCH REVIEWS, 1998, 28 (03) :370-490